Towards Adaptive Bioelectronic Wound Therapy: The a-Heal Wearable Platform
Summary: Researchers have developed a-Heal, a wearable wireless bioelectronic platform that adaptively supports wound healing. By combining real-time imaging, machine learning, and bioelectronic actuators, the system monitors wound stage and delivers personalized therapies, including electric field stimulation and drug delivery. In a porcine wound model, a-Heal accelerated closure, reduced inflammation, and improved tissue regeneration compared to standard care.
Key Highlights:
- Adaptive design: a-Heal integrates an onboard camera with machine learning software to classify wound stage and recommend treatment dynamically.
- Closed-loop function: The platform captures images, analyzes wound state, and automatically adjusts therapy delivery, including electrical stimulation and fluoxetine release.
- Study results: Large-animal testing showed faster re-epithelialization, thicker epidermis, improved collagen type I/III ratio, and reduced granulation tissue compared to controls.
- Immune modulation: Treatment lowered pro-inflammatory markers (IL1B, TNFα), boosted anti-inflammatory signals (IL10, TGFβ1), and promoted regenerative immune responses.
- Clinical potential: a-Heal could extend advanced wound care to underserved or remote settings, though further work is needed to miniaturize the system, test in infected wounds, and evaluate in human trials.
Read the full article in Nature npj Biomedical Innovations
Keywords:
adaptive wound therapy,
bioelectronic wearable,
machine learning,
electric field therapy,
fluoxetine wound healing,
porcine wound model